Article Details
Retrieved on: 2025-08-21 16:32:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Monoclonal antibodies (mAbs) are a powerful class of drug, able to selectively bind to drug targets. An estimated 20% of all new drug approvals ...
Article found on: pharmaceutical-journal.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here